Literature DB >> 26223659

Venous hemostasis postcatheter ablation of atrial fibrillation while under therapeutic levels of oral and intravenous anticoagulation.

Ziad F Issa1,2, Bashar S Amr3.   

Abstract

PURPOSE: Catheter ablation of atrial fibrillation (AF) requires utilizing multiple venous femoral sheaths in conjunction with aggressive periprocedural anticoagulation, which can lead to increased risk of vascular access complications. The objective of this study is to evaluate the safety and efficacy of the "figure-of-eight" ("F-8") suture technique for femoral venous hemostasis while on therapeutic doses of intravenous anticoagulation at the time of sheath removal.
METHODS: In this case-control analysis, 376 consecutive patients underwent AF ablation while on uninterrupted oral anticoagulation and received intraprocedural heparin. In the first 253 patients (the control group), manual pressure was used for femoral venous hemostasis after reversal of heparin effects. The subsequent 123 patients (the F-8 group) had femoral venous hemostasis using the F-8 suture technique and while under therapeutic heparin effects.
RESULTS: The F-8 subcutaneous suture technique achieved adequate venous hemostasis in 98.4% of patients. As compared to the control group, there was significantly less frequent utilization of the FemoStop compression assist device (1.2 vs. 16.8%, p < 0.0001) and in a significantly shorter interval (6.8 ± 5.7 vs. 50.7 ± 12.2 min, p < 0.0001). Vascular access complications and thromboembolic events occurred in 9.8% in the F-8 group vs. 13.0% in the control group (p = 0.678).
CONCLUSIONS: Immediate hemostasis of the femoral venous access sites after insertion of multiple sheaths for AF ablation in the presence of anticoagulation can be safely and effectively achieved using the F-8 suture technique. This technique helps minimize the period of inadequate anticoagulation immediately following ablation and shortens the time required to achieve adequate hemostasis.

Entities:  

Keywords:  Ablation; Anticoagulation; Atrial fibrillation; Vascular hemostasis

Mesh:

Substances:

Year:  2015        PMID: 26223659     DOI: 10.1007/s10840-015-0036-y

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  18 in total

1.  The use of percutaneous suture-mediated closure for the management of 14 French femoral venous access.

Authors:  Ilias Mylonas; Yoshihito Sakata; Michael Salinger; Timothy A Sanborn; Ted Feldman
Journal:  J Invasive Cardiol       Date:  2006-07       Impact factor: 2.022

2.  Technique of temporary subcutaneous "Figure-of-Eight" sutures to achieve hemostasis after removal of large-caliber femoral venous sheaths.

Authors:  Mehmet Cilingiroglu; Michael Salinger; David Zhao; Ted Feldman
Journal:  Catheter Cardiovasc Interv       Date:  2011-07-01       Impact factor: 2.692

3.  Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation.

Authors:  Sandeep Gautam; Roy M John; William G Stevenson; Rahul Jain; Laurence M Epstein; Usha Tedrow; Bruce A Koplan; Seth McClennen; Gregory F Michaud
Journal:  J Cardiovasc Electrophysiol       Date:  2010-08-31

4.  Use of suture-mediated vascular closure devices for the management of femoral vein access after transcatheter procedures.

Authors:  James A Shaw; Elizabeth Dewire; Alan Nugent; Andrew C Eisenhauer
Journal:  Catheter Cardiovasc Interv       Date:  2004-12       Impact factor: 2.692

5.  Pre-closure of femoral venous access sites used for large-sized sheath insertion with the Perclose device in adults undergoing cardiac intervention.

Authors:  V S Mahadevan; S Jimeno; L N Benson; P R McLaughlin; E M Horlick
Journal:  Heart       Date:  2006-11-03       Impact factor: 5.994

6.  Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period.

Authors:  Oussama M Wazni; Salwa Beheiry; Tamer Fahmy; Conor Barrett; Steven Hao; Dimpi Patel; Luigi Di Biase; David O Martin; Mohamed Kanj; Mauricio Arruda; Jennifer Cummings; Robert Schweikert; Walid Saliba; Andrea Natale
Journal:  Circulation       Date:  2007-11-12       Impact factor: 29.690

7.  Real-time ultrasound guidance reduces total and major vascular complications in patients undergoing pulmonary vein antral isolation on therapeutic warfarin.

Authors:  Christine C Tanaka-Esposito; Mina K Chung; Joellyn M Abraham; Daniel J Cantillon; Bernard Abi-Saleh; Patrick J Tchou
Journal:  J Interv Card Electrophysiol       Date:  2013-04-14       Impact factor: 1.900

8.  Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries.

Authors:  Ethan R Ellis; Steven D Culler; April W Simon; Matthew R Reynolds
Journal:  Heart Rhythm       Date:  2009-06-06       Impact factor: 6.343

9.  Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.

Authors:  Mohamed Bassiouny; Walid Saliba; John Rickard; Mingyuan Shao; Albert Sey; Mariam Diab; David O Martin; Ayman Hussein; Maurice Khoury; Bernard Abi-Saleh; Samir Alam; Jay Sengupta; P Peter Borek; Bryan Baranowski; Mark Niebauer; Thomas Callahan; Niraj Varma; Mina Chung; Patrick J Tchou; Mohamed Kanj; Thomas Dresing; Bruce D Lindsay; Oussama Wazni
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-04-03

10.  In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures.

Authors:  Abhishek Deshmukh; Nileshkumar J Patel; Sadip Pant; Neeraj Shah; Ankit Chothani; Kathan Mehta; Peeyush Grover; Vikas Singh; Srikanth Vallurupalli; Ghanshyambhai T Savani; Apurva Badheka; Tushar Tuliani; Kaustubh Dabhadkar; George Dibu; Y Madhu Reddy; Asif Sewani; Marcin Kowalski; Raul Mitrani; Hakan Paydak; Juan F Viles-Gonzalez
Journal:  Circulation       Date:  2013-09-23       Impact factor: 29.690

View more
  3 in total

1.  Feasibility and safety of same-day discharge and shortened bedrest after atrial fibrillation ablation.

Authors:  Benjamin L Freedman; Shu Yang; David Shim; Andre d'Avila; Jonathan W Waks; Patricia Tung
Journal:  J Interv Card Electrophysiol       Date:  2022-05-28       Impact factor: 1.759

2.  Femoral venous hemostasis after atrial fibrillation ablation: Is figure-of-eight suture the way to go?

Authors:  Syeda Atiqa Batul; Rakesh Gopinathannair
Journal:  Indian Pacing Electrophysiol J       Date:  2017-08-31

3.  Figure-of-eight suture for venous hemostasis in fully anticoagulated patients after atrial fibrillation catheter ablation.

Authors:  Umashankar Lakshmanadoss; Wai Shun Wong; Ilana Kutinsky; M Rizwan Khalid; Brian Williamson; David E Haines
Journal:  Indian Pacing Electrophysiol J       Date:  2017-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.